NAPROXEN SODIUM (NSAID) FEVER REDUCER/ PAIN RELIEVER- naproxen sodium tablet 
Amneal Pharmaceuticals of New York LLC

----------

Naproxen Sodium Tablets, USP
Pain Reliever/ Fever Reducer (NSAID)
220 mg

Compared to the active ingredient of Aleve® †

Drug Facts

ACTIVE INGREDIENT

(in each tablet)

Naproxen sodium USP, 220 mg

(naproxen 200 mg) (NSAID)*

*nonsteroidal anti-inflammatory drug

PURPOSE

Pain reliever/fever reducer

INDICATION AND USAGE

Uses

WARNINGS

Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:

Heart attack and stroke warning: NSAID, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

DO NOT USE

ASK DOCTOR/PHARMACIST

Ask a doctor before use if

Ask a doctor or pharmacist before use if you are

WHEN USING

When using this product

STOP USE

Stop use and ask a doctor if

PREGNANCY OR BREAST FEEDING

If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

 Adults and children 12 years and older 
  • take 1 tablet every 8 to 12 hours while symptoms last
  • for the first dose you may take 2 tablets within the first hour
  • do not exceed 2 tablets in any 8- to 12-hour period
  • do not exceed 3 tablets in a 24-hour period
 Children under 12 years 
  • ask a doctor

Other information

  • each tablet contains: sodium 20 mg
  • store at 20 to 25°C (68 to 77°F). Avoid high humidity and excessive heat above 40°C (104°F).

INACTIVE INGREDIENT

croscarmellose sodium, FD&C Blue #2, macrogol, magnesium stearate, polyvinyl alcohol, povidone, pregelatinized starch, talc and titanium dioxide

Questions or Comments?

Call 1-877-835-5472

Monday through Friday 9 AM – 5 PM EST.

Distributed by:

Amneal Pharmaceuticals LLC

Bridgewater, NJ  08807

This product is not manufactured or distributed by Bayer Healthcare, LLC., distributor of Aleve®

Rev. 05-2022-03

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 53746-191-24

Naproxen Sodium Tablets USP (NSAID), 220 mg

24 Tablets

Amneal Pharmaceuticals LLC

01

NDC 53746-192-24

Naproxen Sodium Tablets USP (NSAID), 220 mg

24 Caplets

Amneal Pharmaceuticals LLC

02

NDC 53746-191-24

Naproxen Sodium Tablets USP (NSAID), 220 mg

24 Tablets

Amneal Pharmaceuticals LLC

03

NDC 53746-192-24

Naproxen Sodium Tablets USP (NSAID), 220 mg

24 Caplets

Amneal Pharmaceuticals LLC

04

Purse Pack

NDC 53746-191-08

Naproxen Sodium Tablets USP (NSAID), 220 mg

8 Tablets

Amneal Pharmaceuticals LLC

1

Purse Pack

NDC 53746-192-08

Naproxen Sodium Tablets USP (NSAID), 220 mg

8 Caplets

Amneal Pharmaceuticals LLC

1

Purse Pack

NDC 53746-191-16

Naproxen Sodium Tablets USP (NSAID), 220 mg

16 Tablets

Amneal Pharmaceuticals LLC

1

04

Purse Pack

NDC 53746-192-16

Naproxen Sodium Tablets USP (NSAID), 220 mg

16 Caplets

Amneal Pharmaceuticals LLC

1
06

NAPROXEN SODIUM (NSAID)  FEVER REDUCER/ PAIN RELIEVER
naproxen sodium tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53746-191
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN SODIUM220 mg
Inactive Ingredients
Ingredient NameStrength
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
POVIDONE (UNII: FZ989GH94E)  
STARCH, CORN (UNII: O8232NY3SJ)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorblueScoreno score
ShapeROUND (Biconvex) Size10mm
FlavorImprint Code I3
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53746-191-2424 in 1 BOTTLE; Type 0: Not a Combination Product11/25/2009
2NDC:53746-191-05500 in 1 BOTTLE; Type 0: Not a Combination Product11/25/2009
3NDC:53746-191-088 in 1 VIAL; Type 0: Not a Combination Product11/25/2009
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07909611/25/2009
NAPROXEN SODIUM (NSAID)  FEVER REDUCER/ PAIN RELIEVER
naproxen sodium tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53746-192
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN SODIUM220 mg
Inactive Ingredients
Ingredient NameStrength
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
POVIDONE (UNII: FZ989GH94E)  
STARCH, CORN (UNII: O8232NY3SJ)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorblueScoreno score
ShapeOVAL (Biconvex) Size12mm
FlavorImprint Code I7
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53746-192-088 in 1 VIAL; Type 0: Not a Combination Product11/25/2009
2NDC:53746-192-2424 in 1 BOTTLE; Type 0: Not a Combination Product11/25/2009
3NDC:53746-192-05500 in 1 BOTTLE; Type 0: Not a Combination Product11/25/2009
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07909611/25/2009
Labeler - Amneal Pharmaceuticals of New York LLC (123797875)

Revised: 12/2023
Document Id: 9cc39ab5-450a-4e0b-948d-fdebd66c0f6f
Set id: 0bb41b8c-6031-4e96-95e1-31adab811837
Version: 13
Effective Time: 20231231
 
Amneal Pharmaceuticals of New York LLC